Abstract

http://ssrn.com/abstract=1415972
 
 

Footnotes (4)



 


 



The Ranbaxy - Daiichi Sankyo Deal: Where Do They Go Now?


Shreyash Shah


affiliation not provided to SSRN

Gautam Jain


affiliation not provided to SSRN

Amit Tambade


affiliation not provided to SSRN

Chitra Khatri


affiliation not provided to SSRN

Shuaib M. Fakih


affiliation not provided to SSRN

June 2, 2009


Abstract:     
The announcement of acquisition of Ranbaxy by Daiichi Sankyo in June 2008 was a big surprise in India. Ranbaxy - the largest pharma company in India - was itself growing through acquisition. It had a vision to be in the top 5 global generic pharma company by 2012. Daiichi Sankyo - a Japan-based innovator company - was acquiring a generic company. The price it paid to acquire shares of Ranbaxy represented a premium of 31% over the previous day closing and a premium of 80% over the price prevailing few months before the announcement. The case provides data to examine how Daiichi Sankyo can derive synergies from Ranbaxy. It also shows, through multiples, the likely valuation of Ranbaxy

Number of Pages in PDF File: 21

Keywords: valuation, multiples, synergies, pharma, India

JEL Classification: G34

working papers series


Download This Paper

Date posted: June 9, 2009  

Suggested Citation

Shah, Shreyash and Jain, Gautam and Tambade, Amit and Khatri, Chitra and Fakih, Shuaib M., The Ranbaxy - Daiichi Sankyo Deal: Where Do They Go Now? (June 2, 2009). Available at SSRN: http://ssrn.com/abstract=1415972 or http://dx.doi.org/10.2139/ssrn.1415972

Contact Information

Shreyash Shah
affiliation not provided to SSRN ( email )
Gautam Jain
affiliation not provided to SSRN ( email )
Amit Tambade
affiliation not provided to SSRN ( email )
Chitra Khatri
affiliation not provided to SSRN ( email )
Shuaib M. Fakih (Contact Author)
affiliation not provided to SSRN ( email )
No Address Available
Feedback to SSRN


Paper statistics
Abstract Views: 3,112
Downloads: 984
Download Rank: 11,316
Footnotes:  4

© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.  FAQ   Terms of Use   Privacy Policy   Copyright   Contact Us
This page was processed by apollo3 in 0.500 seconds